• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[通过皮质类固醇、膦甲酸钠和更昔洛韦联合治疗实现的伴有肝细胞功能不全的乙型肝炎病毒再激活的良好病程]

[Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir].

作者信息

Dumortier J, Durupt S, Chevallier M, Trépo C, Zoulim F

机构信息

Service d'Hépatologie, Hôtel-Dieu, Lyon.

出版信息

Gastroenterol Clin Biol. 1997;21(12):982-6.

PMID:9587563
Abstract

Reactivation of hepatitis B virus replication is a rare event during the natural history of chronic hepatitis B. However, the clinical presentation may be severe and an effective therapeutic protocol must be established. We report a case of spontaneous reactivation of hepatitis B virus infection with liver failure. For the moment, no medical treatment has been defined in this situation. A combination of corticosteroids and antiviral drugs (foscarnet and ganciclovir) resulted in clinical and biological recovery, and HBV elimination. If the efficacy of this combined treatment is confirmed in a larger population, this new physiopathological approach should be considered whenever life threatening liver failure occurs.

摘要

乙型肝炎病毒复制再激活是慢性乙型肝炎自然病程中罕见的事件。然而,其临床表现可能很严重,必须建立有效的治疗方案。我们报告一例乙型肝炎病毒感染自发再激活伴肝衰竭的病例。目前,这种情况下尚无明确的药物治疗方法。皮质类固醇与抗病毒药物(膦甲酸钠和更昔洛韦)联合使用导致临床和生物学指标恢复,并清除了乙肝病毒。如果这种联合治疗的疗效在更大规模人群中得到证实,那么每当发生危及生命的肝衰竭时,都应考虑这种新的病理生理学治疗方法。

相似文献

1
[Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir].[通过皮质类固醇、膦甲酸钠和更昔洛韦联合治疗实现的伴有肝细胞功能不全的乙型肝炎病毒再激活的良好病程]
Gastroenterol Clin Biol. 1997;21(12):982-6.
2
Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.化疗引起慢性乙型肝炎病毒感染再激活的抗病毒预防
Clin Liver Dis. 2007 Nov;11(4):965-91, x. doi: 10.1016/j.cld.2007.08.006.
3
Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.
Antiviral Res. 2005 Dec;68(3):147-53. doi: 10.1016/j.antiviral.2005.09.002. Epub 2005 Oct 25.
4
A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.一名乙肝病毒与丙肝病毒合并感染患者在接受α干扰素和利巴韦林联合治疗期间发生严重肝炎发作。
J Gastroenterol. 2003;38(8):796-800. doi: 10.1007/s00535-002-1149-5.
5
Hepatitis B and end-stage liver disease.
Clin Liver Dis. 2007 Nov;11(4):893-916, ix. doi: 10.1016/j.cld.2007.08.009.
6
Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.实体瘤患者接受细胞毒性化疗时的乙肝病毒再激活:前C区/核心区突变可能起重要作用。
J Med Virol. 2000 Mar;60(3):249-55.
7
[Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients].[免疫抑制患者乙肝再激活的预防与治疗]
Dtsch Med Wochenschr. 2009 Feb;134(6):255-8. doi: 10.1055/s-0028-1123989. Epub 2009 Jan 29.
8
Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.英夫利昔单抗治疗克罗恩病患者后发生慢性乙型肝炎再激活:需要进行一级预防。
Gut. 2004 Sep;53(9):1363-5. doi: 10.1136/gut.2004.040675.
9
[Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously cured of hepatitis B].
Gastroenterol Clin Biol. 1999 Jun-Jul;23(6-7):770-4.
10
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.基于氟达拉滨的方案治疗惰性非霍奇金淋巴瘤后乙肝病毒再激活:获得性病毒基因组突变的高发生率
Haematologica. 2003 Nov;88(11):1296-303.

引用本文的文献

1
Glucocorticoid Treatment Strategies in Liver Failure.糖皮质激素在肝衰竭中的治疗策略。
Front Immunol. 2022 Mar 16;13:846091. doi: 10.3389/fimmu.2022.846091. eCollection 2022.